KXU-21822-87402
3 vaccinations
4 coded responses
21 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 857 / AZ
- Registered
- 2021-01-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-25
Dose 1 — Pfizer-BioNTech
-
2021-01-26
Registered in v-safe
-
2021-01-26
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-01-27
- 2021-01-28
- 2021-01-29
-
2021-02-16
Dose 2 — Pfizer-BioNTech
-
2021-02-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-18
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-25
- 2021-03-02
- 2021-03-09
- 2021-03-16
- 2021-03-23
-
2021-04-01
Survey response — day 42, dose 2MedDRA: Haemoptysis — Feeling: GoodFree text: Coughing up bloody mucusMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-18
Survey response — 3 months, dose 2MedDRA: Cough, Rash erythematous — Feeling: GoodFree text: Coughing up mucus, occasionally with red spots in itMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-19
-
2021-12-19
Dose 3 — Moderna
- 2022-02-16
-
2022-06-21
Survey response — 6 months, dose 3MedDRA: Productive cough — Feeling: GoodFree text: Persistent phlegmMedDRA releases: 2024-11 · check-in free text available
-
2022-12-21
Survey response — 12 months, dose 3MedDRA: Abortion spontaneous — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: MiscarriageMedDRA releases: 2024-11 · check-in free text available
-
2022-12-21
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
- 2022-12-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-25 | Pfizer-BioNTech | |
| 2 | 2021-02-16 | Pfizer-BioNTech | |
| 3 | 2021-12-19 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-12-21 | Unsuccessful |
Free text
Release 6 — day 42, dose 2
Symptoms: Coughing up bloody mucus
Release 8 — 3 months, dose 2
Symptoms: Coughing up mucus, occasionally with red spots in it
Release 12 — 6 months, dose 3
Symptoms: Persistent phlegm
Release 12 — 12 months, dose 3
Symptoms: Miscarriage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Haemoptysis | ✓ | ✓ | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Rash erythematous | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release